- Home
- LIQT vs COCP Comparison
LIQT vs COCP Comparison
Compare LIQT & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LIQT | COCP |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7M | 15.6M |
| IPO Year | 2011 | 2011 |
Fundamental Metrics
Financial Performance| Metric | LIQT | COCP |
|---|---|---|
| Price | $1.86 | $1.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $4.30 | ★ $6.00 |
| AVG Volume (30 Days) | 90.9K | ★ 4.3M |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.65 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,712,091.00 |
| Revenue This Year | $42.12 | N/A |
| Revenue Next Year | $63.48 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.22 | $0.86 |
| 52 Week High | $3.35 | $2.19 |
Technical Indicators
Market Signals| Indicator | LIQT | COCP |
|---|---|---|
| Relative Strength Index (RSI) | 53.21 | 66.30 |
| Support Level | $1.37 | $1.48 |
| Resistance Level | $2.06 | $1.99 |
| Average True Range (ATR) | 0.23 | 0.16 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 68.29 | 50.49 |
Price Performance
Historical ComparisonAbout LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in businesses that are liquid filtration market and the silicon carbide ceramic membrane & diesel particulate filter (DPF) market. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and others. Its operating segment includes Water, Ceramics, and Plastics.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).